Atai Life Sciences N.V. (ATAI)
1.24
-0.12 (-8.82%)
At close: Apr 01, 2025, 3:59 PM
1.27
2.83%
Pre-market: Apr 02, 2025, 08:00 AM EDT
Atai Life Sciences Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 17.5M | 45.03M | 190.61M | 362.27M | 97.25M | 30.06M |
| Short-Term Investments | 10M | 134.22M | 82.5M | n/a | n/a | n/a |
| Long-Term Investments | 28.89M | 91.66M | 6.75M | 27.76M | 8.04M | 22.95M |
| Other Long-Term Assets | 42.93M | 14.02M | 10.61M | 11.18M | 3.88M | -22.97M |
| Receivables | 1.35M | 2.26M | 5.63M | n/a | 1.29M | 8.7M |
| Inventory | n/a | n/a | -5.63M | n/a | 457K | 173K |
| Other Current Assets | 52.62M | 846K | 1.75M | 9.77M | 554K | 207K |
| Total Current Assets | 80.13M | 185.59M | 287.14M | 375.08M | 99.55M | 39.15M |
| Property-Plant & Equipment | 3.87M | 2.2M | 928K | 149K | 71K | 21K |
| Goodwill & Intangibles | 3.58M | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 79.26M | 107.89M | 18.3M | 39.08M | 12M | 22.97M |
| Total Assets | 159.39M | 293.48M | 305.44M | 414.17M | 111.55M | 62.12M |
| Account Payables | 2.62M | 4.59M | 2.4M | 6M | 3.08M | 688K |
| Deferred Revenue | n/a | n/a | -180K | n/a | n/a | n/a |
| Short-Term Debt | 6.85M | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 15.48M | 1.1M | 2.24M | 8.24M | 997K | 123K |
| Total Current Liabilities | 24.95M | 20.12M | 19.9M | 20.93M | 12.3M | 1.61M |
| Long-Term Debt | 732K | 17.88M | 15.12M | 743K | 2.18M | 157K |
| Other Long-Term Liabilities | 17.15M | 10.18M | 4.62M | 6.53M | 1.71M | 714K |
| Total Long-Term Liabilities | 17.88M | 29.04M | 280.52M | 384.18M | 3.88M | 871K |
| Total Liabilities | 42.83M | 49.16M | 300.42M | 405.12M | 16.18M | 2.48M |
| Total Debt | 7.58M | 19.14M | 15.12M | 743K | 2.18M | 157K |
| Common Stock | 18.79M | 18.57M | 18.56M | 18M | 13.37M | 10.51M |
| Retained Earnings | -700.21M | -550.94M | -510.19M | -357.8M | -190M | -20.15M |
| Comprehensive Income | -18.47M | -19.46M | -21.7M | -8.34M | 5.82M | -1.43M |
| Shareholders Equity | 116.3M | 242.96M | 260.74M | -348.14M | 90.82M | 58.75M |
| Total Investments | 38.89M | 225.89M | 89.25M | 27.76M | 8.04M | 22.95M |